Today in FirstWord: Gilead Sciences, Sovaldi, velpatasvir, Pfizer, tofacitinib, Merck & Co., bezlotoxumab

Today in FirstWord: Gilead Sciences, Sovaldi, velpatasvir, Pfizer, tofacitinib, Merck &amp; Co., bezlotoxumab

FirstWord Pharmaceutical News for Tuesday, Sep 22, 2015

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional.  For more information on this time-saving tool, please visit www.firstwordpharma.com.

Business

Medicine

Business News

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional. For more information on this time-saving tool, please visit www.firstwordpharma.com.

Share FirstWord Pharmaceutical News for Tuesday, Sep 22, 2015

Sign up to save your podcasts

FirstWord Pharmaceutical News for Tuesday, Sep 22, 2015

FirstWord Pharmaceutical News for Tuesday, Sep 22, 2015